13th Biosimilars Summit
January 23 - 24, 2018 - Alexandria VA US

As more biosimilar products continue to be added to the FDA pipeline, it is critical that pharmaceutical companies develop strategies to comply with evolving regulations, mitigate risk and execute long-term decisions to prepare for success. At CBI’s 13th Biosimilars Summit, you’ll gain insights from industry experts on the tools and strategies needed to prepare for the impending changes impacting all elements of the healthcare industry.

More Information